Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (CLX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
The Clorox Co. Comments On FY 2013 Revenue Guidance; Issues FY 2012 EPS Guidance Below Analysts' Estimates; Updates On FY 2012 Revenue Guidance; Reaffirms FY 2012 EPS Guidance
The Clorox Co. announced that for fiscal 2013, it expects sales growth in the range of 2%-4% and Diluted EPS in the range of $4.20-$4.35. For fiscal 2012, it updated its sales guidance and expects sales growth of about 4%, versus the previous outlook of 2%-4% and diluted earnings per share (EPS) in the range of $4.00-$4.10 for fiscal 2012. The Company reported revenue of $5.23 billion in fiscal 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $5.59 billion and EPS of $4.38 for fiscal 2013; revenue of 5.41 billion and EPS of 4.07 for fiscal 2012.
Latest Developments for The Clorox Co
- The Clorox Co Increases Quarterly Dividend
- The Clorox Co Lowers High End Of Prior FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance; Comments On FY 2014 Revenue Guidance; Issues FY 2014 EPS Guidance In Line With Analysts' Estimates
- The Clorox Co Raises FY 2013 Revenue Guidance; Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
- The Clorox Co Reaffirms FY 2013 Guidance
- Share this
- Link this
- Digg this
Follow Reuters